Severe and prolonged jaundice in a lupus nephritis patient treated with cyclophosphamide.
Moroni
G
G
Division of Nephrology and Dialysis, IRCCS, Ospedale Maggiore, Milano, Italy.
Maccario
M
M
Fargion
S
S
Ponticelli
C
C
D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007565:Jaundice / Q000097:blood / Q000139:chemically induced*; D008181:Lupus Nephritis / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin